{
    "code": "01027346",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01027346",
    "time": "2020-02-25 05:08:49",
    "許可證字號": "衛署藥製字第027346號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/10\/16",
    "註銷理由": "許可證未申請展延",
    "有效日期": "98\/08\/16",
    "發證日期": "72\/08\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102734607",
    "中文品名": "欣辟痛錠２７５公絲（那普洛仙）",
    "英文品名": "NEOPROXEN TABLETS 275MG (NAPROXEN)&quot;SHIN FONG&quot;",
    "適應症": "慢性風濕性關節炎、變形性關節症、腰痛症、急性上氣道炎之消炎、鎮痛、解熱、齒科、口腔外科領域拔牙小手術後之消炎鎮痛",
    "劑型": "110錠劑",
    "包裝": "瓶裝 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 09委託製造",
        "申請商名稱": "6217071706  振貿股份有限公司",
        "申請商地址": "台中市南屯區保安六街102號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808402010",
            "成分名稱": "NAPROXEN SODIUM",
            "含量描述": "275",
            "含量": "275.0000000000",
            "單位": "MG"
        }
    ]
}